Aim & Scope
The Science Set Journal of Cancer Research (ISSN: 3066-8123) aims to serve as a comprehensive and authoritative source of scholarly communication in the field of oncology. The journal’s central objective is to publish original, peer-reviewed articles that enhance understanding of cancer biology, promote innovative treatment strategies, and inform clinical practice across all domains of cancer care. The scope encompasses both laboratory-based research and clinical studies, encouraging interdisciplinary collaboration and global participation.
This journal is positioned to support the growing need for high-quality, accessible research on the prevention, diagnosis, treatment, and management of cancer. It addresses both common malignancies and rare cancers, and gives particular attention to emerging therapeutic modalities, novel biomarkers, epidemiological patterns, and patient-centred outcomes.
Focus on Basic and Translational Cancer Research
Submissions that offer new insights into the molecular and cellular mechanisms of cancer are highly encouraged. This includes studies focused on:
- Genetic and epigenetic alterations in cancer cells
- Oncogenic signalling pathways and cellular proliferation
- Tumour suppressor gene function and mutations
- Mechanisms of metastasis, angiogenesis, and tumour invasion
- Cancer stem cells and microenvironmental influences
Translational research that bridges laboratory science with clinical applications is a critical part of the journal's mission. Articles exploring drug development, therapeutic resistance, or preclinical validation of new compounds are welcome. The journal also supports research that applies systems biology, computational models, or artificial intelligence to advance personalised cancer therapy.
Clinical Oncology and Therapeutic Innovations
The journal publishes clinical research that evaluates new treatment modalities, compares existing therapeutic strategies, or provides real-world evidence on patient outcomes. Topics of interest include:
- Chemotherapy, immunotherapy, radiotherapy, and surgical interventions
- Clinical trials evaluating safety, efficacy, and tolerability
- Biomarker-driven treatment protocols
- Multimodal treatment approaches and combination therapies
- Survivorship care and long-term treatment effects
Studies must be supported by robust methodology, ethical approval, and statistically sound data interpretation. Manuscripts that report on novel clinical protocols or provide practice-changing evidence are prioritized.
Cancer Prevention and Screening
Articles that examine cancer risk factors, preventive interventions, or screening programs are considered within scope. The journal invites submissions addressing:
- Lifestyle and behavioural interventions for cancer risk reduction
- Vaccination strategies, such as HPV-related cancer prevention
- Public health initiatives to promote cancer screening
- Cost-effectiveness and outcomes of early detection methods
- Genetic testing and counselling for hereditary cancer syndromes
Public health studies with a strong analytical component that can influence policy or improve community health are of particular interest.
Diagnostic Advancements and Biomarkers
This section of the journal covers research into the development and application of diagnostic technologies, with an emphasis on:
- Imaging modalities, molecular diagnostics, and pathology techniques
- Circulating tumour DNA and liquid biopsy applications
- Genomic and proteomic biomarkers for diagnosis and prognosis
- Integration of diagnostics into treatment decision-making
Submissions in this area should demonstrate the clinical utility and potential for implementation in practice.
Epidemiology, Global Oncology, and Health Equity
Cancer is a global health issue, and this journal recognizes the importance of research that spans geographical boundaries and highlights disparities in care. Submissions may include:
- Descriptive and analytical cancer epidemiology
- Global cancer burden and resource-limited settings
- Health equity, access to care, and cultural competence in oncology
- Cancer control programs and population-level interventions
- Impact of socioeconomic and environmental factors on cancer risk
- Studies from underrepresented regions or focused on vulnerable populations are strongly encouraged.
Psychosocial Oncology, Nursing, and Palliative Care
Beyond diagnosis and treatment, cancer has a profound psychological, emotional, and social impact. This journal values research that emphasises the human experience of cancer, including:
- Quality of life assessments and psychosocial interventions
- Oncology nursing practices and models of care
- Communication between patients and healthcare teams
- Palliative care, symptom management, and supportive services
- End-of-life decision-making and caregiver experiences
Submissions should offer evidence-based approaches that support patient well-being and holistic cancer care.
Innovation and Interdisciplinary Collaboration
The Science Set Journal of Cancer Research promotes interdisciplinary research that integrates oncology with other fields, including:
- Bioinformatics, data science, and machine learning
- Nanotechnology and drug delivery systems
- Biomedical engineering for cancer diagnostics or therapy
- Health economics and policy research in cancer care
- Behavioural science and cancer survivorship research
Authors are encouraged to submit work that involves collaboration between clinicians, scientists, technologists, public health experts, and policy makers.
Commitment to Scientific Integrity and Advancement
The journal seeks to uphold rigorous standards in all stages of research and publication. Each accepted article is expected to contribute meaningfully to the academic community and demonstrate relevance to advancing the fight against cancer. By encouraging a wide variety of topics and formats—from foundational studies to practice-changing clinical trials, the Science Set Journal of Cancer Research aims to remain a leading venue for timely, impactful oncology research.
